178 related articles for article (PubMed ID: 8333538)
1. Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
Monte MJ; Badia MD; Palomero F; el-Mir MY; Alonso JR; Marin JJ
Am J Physiol; 1993 Jun; 264(6 Pt 1):G1103-11. PubMed ID: 8333538
[TBL] [Abstract][Full Text] [Related]
2. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
Lake JR; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
[TBL] [Abstract][Full Text] [Related]
3. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
4. Pre-replicative phase-related changes in bile acid-induced choleresis in the regenerating rat liver.
Garcia-Marin JJ; Regueiro P; Perez-Antona JC; Villanueva GR; Perez-Barriocanal F
Clin Sci (Lond); 1990 Jan; 78(1):55-62. PubMed ID: 2153496
[TBL] [Abstract][Full Text] [Related]
5. Formation of biliary thrombi in protoporphyrin-induced cholestasis in perfused rat liver.
Berenson MM; Gunther C; Samowitz WS; Bjorkman DJ
Hepatology; 1990 May; 11(5):757-63. PubMed ID: 2347550
[TBL] [Abstract][Full Text] [Related]
6. Effect of bile acids on hepatobiliary transport of cisplatin by perfused rat liver.
Villanueva GR; Mendoza ME; el-Mir MY; Monte MJ; Herrera MC; Marin JJ
Pharmacol Toxicol; 1997 Mar; 80(3):111-7. PubMed ID: 9101582
[TBL] [Abstract][Full Text] [Related]
7. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
10. Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.
Gurantz D; Schteingart CD; Hagey LR; Steinbach JH; Grotmol T; Hofmann AF
Hepatology; 1991 Mar; 13(3):540-50. PubMed ID: 1999323
[TBL] [Abstract][Full Text] [Related]
11. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
13. Competition in liver transport between chenodeoxycholic acid and ursodeoxycholic acid as a mechanism for ursodeoxycholic acid and its amidates' protection of liver damage induced by chenodeoxycholic acid.
Piazza F; Montagnani M; Russo C; Azzaroli F; Aldini R; Roda E; Roda A
Dig Liver Dis; 2000 May; 32(4):318-28. PubMed ID: 11515630
[TBL] [Abstract][Full Text] [Related]
14. cGMP stimulates bile acid-independent bile formation and biliary bicarbonate excretion.
Myers NC; Grune S; Jameson HL; Sawkat-Anwer M
Am J Physiol; 1996 Mar; 270(3 Pt 1):G418-24. PubMed ID: 8638707
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
16. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
Vore M; Durham S; Yeh S; Ganguly T
Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
[TBL] [Abstract][Full Text] [Related]
17. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
[TBL] [Abstract][Full Text] [Related]
18. Bile acid-induced modifications in DNA synthesis by the regenerating perfused rat liver.
Marin JJ; Barbero ER; Herrera MC; Tabernero A; Monte MJ
Hepatology; 1993 Nov; 18(5):1182-92. PubMed ID: 8225225
[TBL] [Abstract][Full Text] [Related]
19. Effect of insulin and glucose load on bile lactate secretion by the isolated rat liver. Role of hepatic parenchyma heterogeneity.
Villanueva GR; el-Mir MY; Perez-Barriocanal F; Bravo P; Marin JJ
Biochim Biophys Acta; 1993 Aug; 1158(1):8-14. PubMed ID: 8353135
[TBL] [Abstract][Full Text] [Related]
20. Effect of bile acids on absorption of nitrendipine in healthy subjects.
Sasaki M; Maeda A; Sakamoto K; Fujimura A
Br J Clin Pharmacol; 2001 Dec; 52(6):699-701. PubMed ID: 11736882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
